Core Insights - The announcement of the completion of the ETHK building marks a significant milestone for the company as it transitions to a new strategic focus on blockchain technology and compliance in the financial ecosystem [4][5][8] - The new logo symbolizes the company's evolution into a builder of next-generation on-chain financial ecosystems, moving beyond its previous identity [4][8] Group 1: ETHK Building and Its Significance - The ETHK building is the world's first core base dedicated to the research and ecological empowerment of Real World Assets (RWA) digitalization technology, located in Nanjing with a total area of approximately 70,000 square meters [5][7] - The building serves a dual purpose: as a physical infrastructure for research and collaboration, and as a credible technology development and output center, expected to gather over 5,000 technical experts and engineers [7][8] - Nanjing was chosen for its strategic alignment with the company's focus on high-tech intellectual property asset digitalization and its proximity to top universities, providing talent support [7][8] Group 2: RWA Ecosystem and Strategic Transformation - The logo update and building completion represent the company's "second entrepreneurship," fully transitioning to the RWA sector, which involves the tokenization of real-world assets [8][9] - The RWA market is projected to grow significantly, with a total locked value expected to reach $12.5 billion by June 2025, a 124% increase from 2024 [8][9] - The company has established ETHK Inc. and ETHK HOLDINGS LIMITED to position itself as a technology driver and infrastructure provider in the RWA ecosystem [8][9] Group 3: Strategic Partnerships and Business Model Innovation - The company announced a strategic partnership with Renhe Pharmaceutical to establish the world's first OTC vertical RWA exchange in the U.S., marking a key case for its "exchange within an exchange" business model [9][10] - This innovative model aims to provide on-chain financial infrastructure for leading enterprises across various industries, facilitating the creation of vertical RWA exchanges [10] - The partnership is expected to enhance both parties' capabilities, enabling the internationalization of Chinese assets and the introduction of innovative OTC products from abroad [10][11] Group 4: Value Creation and Market Potential - The company's RWA strategy aims to create multidimensional value, emphasizing altruistic values and contributing to national strategies and public welfare [11][12] - The collaboration with Renhe Pharmaceutical is set to revolutionize the OTC industry by enhancing innovation efficiency across the entire value chain [11][12] - The RWA market is on the verge of significant growth, with major financial institutions entering the space, positioning the company to lead in this emerging sector [12][13]

Core Viewpoint - The announcement by Huajian Medical (01931.HK) regarding the establishment of joint ventures and a rebranding signifies a strategic shift towards "on-chain finance," aiming to build the next generation of global asset circulation infrastructure [1][3]. Group 1: Strategic Shift - The name change from "IVD Medical Holding Limited" to "ETHK Labs Inc." reflects a new strategic vision that aligns with its role as a key technology and infrastructure provider in the "ETHK on-chain financial ecosystem" [1][3]. - The establishment of joint ventures alongside the rebranding indicates a systematic increase in investment in digital industries and on-chain finance, suggesting a long-term commitment rather than short-term market speculation [3]. Group 2: Trust Mechanism - There are two contrasting perspectives on Huajian Medical's transformation: supporters believe blockchain can effectively address global asset liquidity issues, while skeptics question the scalability of RWA (Real World Asset) and the clarity of the business model [4][6]. - The ability to build a sustainable, regulatory-compliant, and scalable trust system is crucial for the success of Huajian Medical's strategy [6]. Group 3: Strategic Drivers - The transformation is driven by three factors: the need to overcome growth bottlenecks in existing business, the necessity to attract investor attention with a new global and tech-oriented narrative, and the supportive policy environment in Hong Kong for Web3 and digital asset innovation [8]. Group 4: Value Distribution - Huajian Medical's ETHK ecosystem aims to create new opportunities for asset owners by providing pathways for financing and global market access through on-chain tools [9]. - For capital providers, Huajian Medical is expected to offer new investment interfaces that connect them to high-quality assets traditionally overlooked by the financial system [9]. Group 5: Conclusion - The establishment of joint ventures and the rebranding highlight a significant trend where Chinese quality assets are attempting to achieve global circulation through blockchain technology, while global capital seeks new value anchors [11]. - The success of Huajian Medical in converting its narrative of "on-chain finance" into a credible, investable, and sustainable reality will depend on its ability to address technical implementation, compliance, business models, and ecosystem collaboration [11][12].

Core Viewpoint - The announcement by Huajian Medical on September 14 signifies a strategic shift towards integrating the pharmaceutical industry with blockchain finance, indicating a new attempt for Chinese quality assets to go global [1][5]. Group 1: Company Strategy - Huajian Medical is transitioning to focus on digital industries and blockchain finance to create new growth avenues and enhance long-term shareholder value [6]. - The rebranding to "ETHK Labs Inc." reflects the company's new positioning as a key technology and infrastructure provider within the ETHK blockchain financial ecosystem [6][11]. - The establishment of ETHK INC and ETHK HOLDINGS LIMITED aims to develop a decentralized financial platform and serve as an investment and acquisition hub for digital industries [7][11]. Group 2: Global Asset Tokenization - Huajian Medical's strategy includes exploring the tokenization of global assets, particularly focusing on the tokenization of equity assets, which allows for efficient and compliant global financing and value discovery [9]. - The initiative aims to convert research outcomes and intellectual property into tradable digital assets, broadening financing channels for companies [9]. Group 3: Compliance and Security - The joint venture emphasizes compliance and security, seeking relevant financial and payment licenses globally, and establishing a comprehensive compliance framework [10]. - The framework includes KYC, AML, and CFT procedures, along with risk management tools to ensure the secure circulation of innovative assets on the blockchain [10]. Group 4: Strategic Significance - The collaboration with ETHK Group represents a significant upgrade in Huajian Medical's strategy, aligning with the global trend of financial asset digitization and blockchain integration [11]. - This strategic layout provides a broader platform for quality assets and diverse investment opportunities while ensuring safety through a strict compliance framework [11]. Group 5: Future Considerations - The development of the blockchain financial ecosystem is still in its early stages, facing challenges in technology, regulation, and market perception [13]. - Key questions include how to overcome technical barriers, establish a unified regulatory framework, and enhance market participants' understanding of blockchain finance [13].

Group 1 - The company officially announced its name change to "ETHK Labs Inc." and updated its Chinese name to "华检数字产业集团有限公司" [1] - This name change signifies a comprehensive strategic upgrade, shifting focus towards core technology research and output in the digital industry and blockchain financial ecosystem [1] - The aim of the rebranding is to better reflect the company's new positioning as a key technology provider in the "ETHK" blockchain financial ecosystem, enhancing its competitiveness and influence in the global digital asset ecosystem [1]

Core Viewpoint - Huajian Medical (1931.HK) has announced a strategic partnership with ETHK Group to establish two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, aimed at enhancing its position in the blockchain financial ecosystem [1] Group 1: Strategic Partnership - The collaboration with ETHK Group signifies a strategic upgrade for Huajian Medical as a provider of blockchain financial infrastructure [1] - ETHK Inc will focus on creating a compliant and open decentralized financial platform [1] - ETHK HOLDINGS LIMITED will be responsible for global digital industry investments and mergers and acquisitions [1] Group 2: Business Model - The new companies will integrate resources through a "assets-funds-licenses" triad model [1] - This initiative aims to promote the overseas expansion of quality Chinese assets [1] - The partnership seeks to establish a new paradigm for global value flow [1]

Core Viewpoint - The company proposes to change its English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" to better reflect its strategic direction and focus on digital industries and blockchain financial ecosystems [1] Group 1 - The company aims to consolidate its existing business while actively exploring and positioning itself in cutting-edge fields such as digital industries and blockchain finance [1] - The name change is part of a broader strategy to establish a joint venture and deepen the global blockchain financial ecosystem under the "ETHK" core brand [1] - The board believes that the new name will better represent the company's ambition to become a key technology and infrastructure provider within the "ETHK" blockchain financial ecosystem [1]